Innoviva Company Profile (NASDAQ:INVA)

About Innoviva

Innoviva logoInnoviva, Inc., formerly Theravance, Inc., focuses on bringing new medicines to patients in areas of unmet need. The Company is engaged in the development, commercialization and financial management of bio-pharmaceuticals. Its portfolio focuses on the respiratory assets partnered with Glaxo Group Limited (GSK), including RELVAR/BREO ELLIPTA (fluticasone furoate/vilanterol (FF/VI)) and ANORO ELLIPTA (umeclidinium bromide/vilanterol (UMEC/VI)). It operates in providing capital return to stockholders by maximizing the potential value of its respiratory assets partnered with GSK segment. RELVAR/BREO is a once-a-day combination inhaled respiratory medicine consisting of VI, a LABA and FF, an inhaled corticosteroid (FF/VI) delivered via the ELLIPTA dry powder inhaler. ANORO ELLIPTA is a dual bronchodilator consisting of UMEC, a long-acting muscarinic antagonist (LAMA) and VI, a LABA for the treatment of chronic obstructive pulmonary diseases (COPD).

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: INVA
  • CUSIP: 88338T10
Key Metrics:
  • Previous Close: $11.38
  • 50 Day Moving Average: $11.99
  • 200 Day Moving Average: $11.87
  • Trailing P/E Ratio: 68.97
  • Foreward P/E Ratio: 9.98
  • P/E Growth: 0.25
  • Market Cap: $1.27B
  • Outstanding Shares: 111,202,000
  • Beta: 1.71
Additional Links:
Companies Related to Innoviva:

Analyst Ratings

Consensus Ratings for Innoviva (NASDAQ:INVA) (?)
Ratings Breakdown: 4 Hold Ratings, 1 Buy Rating
Consensus Rating:Hold (Score: 2.20)
Consensus Price Target: $11.60 (1.93% upside)

Analysts' Ratings History for Innoviva (NASDAQ:INVA)
Show:
DateFirmActionRatingPrice TargetDetails
7/31/2016Robert W. BairdReiterated RatingNeutral$9.00 -> $11.00View Rating Details
10/29/2015Cowen and CompanyLower Price TargetMarket Perform$15.00 -> $10.00View Rating Details
10/5/2015Morgan StanleyReiterated RatingOverweight$7.00 -> $9.00View Rating Details
9/10/2015Sanford C. BernsteinReiterated RatingMarket Perform$15.00View Rating Details
9/9/2015Bank of America Corp.DowngradeBuy -> Neutral$16.00 -> $13.00View Rating Details
12/2/2014Leerink SwannDowngradeOutperform -> Market Perform$17.00View Rating Details
(Data available from 8/28/2014 forward)

Earnings

Earnings History for Innoviva (NASDAQ:INVA)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/26/2016        
7/28/2016Q216$0.11$0.17$31.13 million$32.47 millionViewListenView Earnings Details
4/28/2016Q116$0.09$0.04$28.61 million$24.17 millionViewListenView Earnings Details
2/3/2016Q415$0.01$0.04$20.17 million$22.80 millionViewN/AView Earnings Details
10/28/2015Q315($0.03)($0.04)$15.23 million$13.56 millionViewListenView Earnings Details
7/29/2015Q2($0.06)($0.07)$10.90 million$10.70 millionViewListenView Earnings Details
5/6/2015Q115($0.08)($0.09)$6.80 millionViewListenView Earnings Details
2/18/2015Q414($0.15)($0.14)$5.42 million$7.30 millionViewN/AView Earnings Details
10/30/2014Q314($0.14)($0.19)$6.30 millionViewN/AView Earnings Details
8/18/2014($0.53)($0.18)ViewN/AView Earnings Details
8/6/2014Q214($0.44)($0.57)$4.39 million$0.93 millionViewN/AView Earnings Details
5/6/2014Q114($0.53)($0.62)$4.52 million$0.17 millionViewN/AView Earnings Details
2/6/2014Q413($0.38)($0.46)$6.03 million$1.60 millionViewN/AView Earnings Details
10/24/2013Q313$0.69($0.44)$3.08 million$0.44 millionViewN/AView Earnings Details
7/25/2013Q2 2013($0.46)($0.37)$1.43 million$1.33 millionViewN/AView Earnings Details
4/25/2013Q1 2013($0.38)($0.39)$2.71 million$1.34 millionViewN/AView Earnings Details
2/12/2013Q4 2012($0.36)($0.33)$3.88 million$5.80 millionViewN/AView Earnings Details
10/30/2012($0.39)($0.37)ViewN/AView Earnings Details
7/31/2012($0.42)($0.42)ViewN/AView Earnings Details
4/26/2012$1.02$0.93ViewN/AView Earnings Details
2/9/2012($0.38)($0.45)ViewN/AView Earnings Details
10/27/2011($0.33)($0.37)ViewN/AView Earnings Details
7/28/2011($0.27)($0.31)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Innoviva (NASDAQ:INVA)
Current Year EPS Consensus Estimate: $0.6 EPS
Next Year EPS Consensus Estimate: $1.14 EPS

Dividends

Current Dividend Information for Innoviva (NASDAQ:INVA)
Annual Dividend:$0.25
Dividend Yield:2.20%
Payout Ratio:147.07% (Based on Trailing 12 Months of Earnings)
41.67% (Based on Current Year Consensus EPS Estimate)
21.93% (Based on Next Year Consensus EPS Estimate)

Dividend History for Innoviva (NASDAQ:INVA)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
7/30/2015quarterly$0.257.01%9/8/20159/10/20159/30/2015
5/7/2015quarterly$0.256.43%6/10/20156/12/20156/30/2015
2/24/2015quarterly$0.255.85%3/10/20153/12/20153/31/2015
10/31/2014quarterly$0.256.24%11/21/201411/25/201412/23/2014
8/6/2014quarterly$0.258/26/20148/28/20149/18/2014
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Innoviva (NASDAQ:INVA)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/22/2016Eric DesparbesCFOSell3,700$11.77$43,549.00View SEC Filing  
5/18/2016James L TyreeDirectorSell813$10.47$8,512.11View SEC Filing  
5/11/2015Plc GlaxosmithklineMajor ShareholderBuy85,579$1,369,260.00$117,179,901,540.00View SEC Filing  
8/13/2014Junning LeeVPSell53,424$22.50$1,202,040.00View SEC Filing  
8/12/2014Bradford J ShaferSVPSell28,156$22.13$623,092.28View SEC Filing  
8/11/2014Bradford J ShaferSVPSell27,108$22.12$599,628.96View SEC Filing  
9/12/2013Rick WinninghamCEOSell22,353$40.03$894,790.59View SEC Filing  
7/30/2013Mathai MammenSVPSell7,000$36.51$255,570.00View SEC Filing  
6/7/2013Bradford J ShaferSVPSell31,038$35.04$1,087,571.52View SEC Filing  
5/29/2013David L BrinkleyInsiderSell3,808$35.01$133,318.08View SEC Filing  
5/13/2013David L BrinkleyInsiderSell16,129$40.33$650,482.57View SEC Filing  
8/7/2012Michael W AguiarCFOSell60,000$27.04$1,622,400.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Innoviva (NASDAQ:INVA)
DateHeadline
nasdaq.com logoInnoviva Breaks Below 200-Day Moving Average - Notable for INVA - Nasdaq (NASDAQ:INVA)
www.nasdaq.com - August 25 at 5:41 PM
nasdaq.com logoInnoviva Breaks Below 200-Day Moving Average - Notable for INVA (NASDAQ:INVA)
www.nasdaq.com - August 25 at 10:41 AM
nasdaq.com logoInnoviva Becomes Oversold (INVA) (NASDAQ:INVA)
www.nasdaq.com - August 24 at 5:33 PM
News IconStock Gaining Over the Past Six Months: Innoviva, Inc. (:INVA) - Post News (NASDAQ:INVA)
www.kentuckypostnews.com - August 22 at 10:14 AM
News IconShares Holding Above Moving Averages: Innoviva, Inc. (:INVA) - Post News (NASDAQ:INVA)
www.kentuckypostnews.com - August 19 at 5:40 PM
News IconInstitutions Have Decreased Their Ownership of Innoviva, Inc. (:INVA) - Post News (NASDAQ:INVA)
www.kentuckypostnews.com - August 19 at 8:38 AM
investopedia.com logo3 Pullback Plays For A Quiet Summer Market (JCP, ADXS) (NASDAQ:INVA)
www.investopedia.com - August 18 at 5:41 PM
finance.yahoo.com logoINNOVIVA, INC. Financials (NASDAQ:INVA)
finance.yahoo.com - August 12 at 5:45 PM
thestreet.com logoOverboarded Directors at Valeant, Yahoo! and Elsewhere Struggle With Activists, M&A (NASDAQ:INVA)
www.thestreet.com - August 12 at 5:45 PM
capitalcube.com logoETF’s with exposure to Innoviva, Inc. : August 5, 2016 (NASDAQ:INVA)
www.capitalcube.com - August 5 at 5:49 PM
biz.yahoo.com logoINNOVIVA, INC. Files SEC form 10-Q, Quarterly Report (NASDAQ:INVA)
biz.yahoo.com - August 5 at 8:41 AM
capitalcube.com logoInnoviva, Inc. :INVA-US: Earnings Analysis: Q2, 2016 By the Numbers : August 3, 2016 (NASDAQ:INVA)
www.capitalcube.com - August 3 at 5:59 PM
finance.yahoo.com logoKeryx (KERX) Stock Down on Wider Q2 Loss, Supply Issues (NASDAQ:INVA)
finance.yahoo.com - August 2 at 10:29 AM
seekingalpha.com logoInnoviva: Finally Starting To Gain Some Trust - Seeking Alpha (NASDAQ:INVA)
seekingalpha.com - July 31 at 5:21 PM
finance.yahoo.com logoEdited Transcript of INVA earnings conference call or presentation 28-Jul-16 9:00pm GMT (NASDAQ:INVA)
finance.yahoo.com - July 29 at 4:20 PM
businesswire.com logoInnoviva Reports Second Quarter 2016 Financial Results - Business Wire (press release) (NASDAQ:INVA)
www.businesswire.com - July 29 at 8:37 AM
sg.finance.yahoo.com logoInnoviva beats 2Q profit forecasts (NASDAQ:INVA)
sg.finance.yahoo.com - July 28 at 6:34 PM
finance.yahoo.com logo4:17 pm Innoviva reports EPS in-line, beats on revs (NASDAQ:INVA)
finance.yahoo.com - July 28 at 4:17 PM
biz.yahoo.com logoINNOVIVA, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits (NASDAQ:INVA)
biz.yahoo.com - July 28 at 4:14 PM
finance.yahoo.com logoInnoviva Reports Second Quarter 2016 Financial Results (NASDAQ:INVA)
finance.yahoo.com - July 28 at 4:05 PM
nasdaq.com logoVertex (VRTX) Posts Narrower Q2 Loss, Revenues Fall Short - Nasdaq (NASDAQ:INVA)
www.nasdaq.com - July 28 at 8:41 AM
finance.yahoo.com logoAmgen (AMGN) Tops Q2 Earnings & Revenues, Raises View (NASDAQ:INVA)
finance.yahoo.com - July 28 at 8:02 AM
biz.yahoo.com logoQ2 2016 Innoviva Inc Earnings Release - After Market Close (NASDAQ:INVA)
biz.yahoo.com - July 28 at 7:07 AM
News IconInnoviva, Inc. (NASDAQ:INVA) To Report June 2016 Results - The Voice Registrar (NASDAQ:INVA)
voiceregistrar.com - July 27 at 8:28 AM
finance.yahoo.com logoAfter GILD Earnings, Which Biomed Stock is Best Right Now? (NASDAQ:INVA)
finance.yahoo.com - July 26 at 4:55 PM
nasdaq.com logoNotable Monday Option Activity: CAVM, INVA, BWLD - Nasdaq (NASDAQ:INVA)
www.nasdaq.com - July 26 at 8:37 AM
finance.yahoo.com logoShould You Buy Innoviva (INVA) Ahead of Earnings? (NASDAQ:INVA)
finance.yahoo.com - July 26 at 8:36 AM
nasdaq.com logoActelion (ALIOF) Beats Q2 Earnings & Revenues, View Up - Nasdaq (NASDAQ:INVA)
www.nasdaq.com - July 24 at 5:20 PM
finance.yahoo.com logoSynta (SNTA) Cuts Q2 Loss Y/Y, Madrigal Merger in Focus (NASDAQ:INVA)
finance.yahoo.com - July 23 at 9:40 AM
nasdaq.com logoAegerion to Withdraw Juxtapid from EU, Reduces Workforce - Nasdaq (NASDAQ:INVA)
www.nasdaq.com - July 22 at 5:36 PM
News IconEarnings Quick View: Centene Corporation (NYSE:CNC), Terreno Realty Corporation (NYSE:TRNO), Globant S.A. ... - Engelwood Daily (NASDAQ:INVA)
www.engelwooddaily.com - July 22 at 5:36 PM
finance.yahoo.com logoSynta (SNTA) Cuts Q2 Loss Y/Y, Madrigal Merger in Focus - Yahoo Finance (NASDAQ:INVA)
finance.yahoo.com - July 22 at 5:36 PM
News IconInnoviva, Inc. (NASDAQ:INVA) Upcoming Earnings: What matter for investors? - The Voice Registrar (NASDAQ:INVA)
voiceregistrar.com - July 22 at 5:36 PM
finance.yahoo.com logoBiogen (BIIB) Stock Up on Q2 Earnings Beat, Raised Outlook (NASDAQ:INVA)
finance.yahoo.com - July 21 at 11:42 AM
finance.yahoo.com logoInnoviva to Report Second Quarter 2016 Financial Results on July 28 at 5:00 p.m. EDT (NASDAQ:INVA)
finance.yahoo.com - July 20 at 4:05 PM
nasdaq.com logoCelgene's Revlimid Gains EU Nod for Mantle Cell Lymphoma - Nasdaq (NASDAQ:INVA)
www.nasdaq.com - July 20 at 3:41 PM
finance.yahoo.com logoAstraZeneca's (AZN) Tagrisso Hits Phase III Primary Endpoint - Yahoo Finance (NASDAQ:INVA)
finance.yahoo.com - July 20 at 3:41 PM
nasdaq.com logoEvoke (EVOK) Stock Down on Poor Phase III EVK-001 Data - Nasdaq (NASDAQ:INVA)
www.nasdaq.com - July 20 at 8:40 AM
nasdaq.com logoBristol-Myers' Opdivo Label Expansion Under U.S., EU Review - Nasdaq (NASDAQ:INVA)
www.nasdaq.com - July 20 at 8:40 AM
nasdaq.com logoAstraZeneca's (AZN) Tagrisso Hits Phase III Primary Endpoint - Nasdaq (NASDAQ:INVA)
www.nasdaq.com - July 20 at 8:40 AM
finance.yahoo.com logoZIOPHARM (ZIOP) Stock Down on Patient Death in Phase I (NASDAQ:INVA)
finance.yahoo.com - July 18 at 10:55 AM
finance.yahoo.com logoEli Lilly, Boehringer Collaborate for Metastatic Breast Cancer (NASDAQ:INVA)
finance.yahoo.com - July 14 at 5:49 PM
News IconWhat's Propelling Innoviva Inc to Increase So Much? - Consumer Eagle (NASDAQ:INVA)
www.consumereagle.com - July 14 at 9:11 AM
nasdaq.com logoCytRx (CYTR) Stock Falls on Unfavorable Aldoxorubicin Data - Nasdaq (NASDAQ:INVA)
www.nasdaq.com - July 13 at 8:35 AM
News IconStock Providing Gains on the Month for Investors: Innoviva, Inc. (:INVA) - Telanagana Press (NASDAQ:INVA)
telanaganapress.com - July 13 at 8:35 AM
finance.yahoo.com logoGilead's Pan-Genotypic HCV Drug Epclusa Gains EU Approval - Yahoo Finance (NASDAQ:INVA)
finance.yahoo.com - July 12 at 5:55 PM
finance.yahoo.com logoLigand (LGND) Signs Deal with Gilead for OmniAb Technology - Yahoo Finance (NASDAQ:INVA)
finance.yahoo.com - July 12 at 5:55 PM
gurufocus.com logoSeth Klarman Buys —5 Million Shares of Cascadian Therapeutics - GuruFocus.com (NASDAQ:INVA)
www.gurufocus.com - July 12 at 5:55 PM
nasdaq.com logoAbbVie's ABT-414 Gets Rare Pediatric Disease Status in U.S. - Nasdaq (NASDAQ:INVA)
www.nasdaq.com - July 12 at 5:55 PM
zacks.com logoAbbVie's ABT-414 Gets Rare Pediatric Disease Status in U.S. (NASDAQ:INVA)
www.zacks.com - July 12 at 10:02 AM

Social

Innoviva (NASDAQ:INVA) Chart for Sunday, August, 28, 2016


Last Updated on 8/28/2016 by MarketBeat.com Staff